(Q40682603)
Statements
Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway (English)
Hidesuke Fukazawa
Kohji Noguchi
Yuko Murakami
Yoshimasa Uehara